A new study shows that the health of U.S. children has deteriorated over the past 17 years, with kids today more likely to ...

But now is not the time to retreat into our homes to "protect" our children, pediatrician Dr. Christopher Forrest told ...

Brain differences in children and teens who experiment with drugs early show up before they take their first puff or sip ...

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.

Cogent Biosciences said its experimental drug reduced the symptoms of a chronic immune disorder called indolent systemic ...

After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.